A descriptive and prognostic study of systemic sclerosis-associated myopathies. Muscle histopathology is critical in the therapeutic management of SSc-associated myopathy, because patients without muscle inflammation are unlikely to get benefit from corticosteroid therapy. B Ranque. Annals of Rheumatic Diseases. 3 December 2008. (Also see: Skeletal Involvement)
This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Systemic Sclerosis-Associated Myopathies
No replies to this topic